Medical Marijuana reaches relief results in remedying the symptoms of autism …
In a new study of a group of researchers in Brazil, children and adolescents had a positive impact on medical marijuana (especially Kanapitla (CPD)) on symptoms of autism.
This study is one of the first research that illustrates Kanapitla’s role in the treatment of autism spectrum disorders that affect many children around the world.
Researchers assessed the 276 participants between the ages of 5 to 21, which was found to have autism, and they distributed the increasing number of Kanapitla (CPD) or fake medicine for the increasing number.
The treatment began with 1 mg of body weight, and gradually increased to 10 mg of body weight. The liquid sizes of the natural mixture of the jute plant are used, which does not have the psychological effects known from the other mixture in marijuana, which is four times the hydroceanabinol (thc).
The results of the study showed significant progress in the social skills of children and adolescents who took Canabitla, because they were able to understand social signals and communicate with others better. They expressed progress in improveing sleep, reducing the amount of tension, and reducing irritable behavior such as aggression and anger attacks.
Researchers have pointed out that Kanapitla does not show severe side -effects such as fatigue or appetite, which improves the opportunity to use it as a safe treatment with traditional treatment of autism spectrum disorder.
Researchers have warned that these results do not mean that these results are a final treatment for this disorder because the current study is low due to the lack of diversity of a lower number of studies and samples.
However, this study shows the best possibilities to expand the use of Kanabidad (CPD) as part of a treatment plan that complements traditional treatments.
Researchers have pointed out the need to conduct more medical experiences and large studies to determine the efficiency and safety of the cannabis for a long time, including assessing the potential effects of this treatment in various cases of autism spectrum disorder.
In this study, “Dr. Lara Kaplett Beniti, a prominent researcher at the University of Sawo Palo, Brazil, said: The results of the study are encouraging, but we need additional research to clarify the efficiency and safety of the cannabis in managing these disorders. “
It should be noted that the CBT does not have ecstasy or psychological effects. Therefore, many experts believe that Kanapitla is useful to treat many cases such as leg -epilepsy and other brain disorders, which may explain the positive effects he has shown in autism.
It is also more likely that the molecules and the nervous system activate the nervous system associated with the canapinoid receptors in the brain, which may contribute to the brain functions and some of the immune system. Daily mail
